PGEN vs RXRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
PGEN
RXRX
Investment Advisor Scores
RXRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PGEN | RXRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 270.2703 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1633.9% | -56.1% | PGEN |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.0/100 | 53.9/100 | PGEN |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | PGEN |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PGEN
MarkupPrice above SMA50, rising 50-day trend (11.4% over 20 days), RSI 71
RXRX
NeutralMixed signals - no dominant trend phase, RSI 47
Fundamentals Snapshot
| Metric | PGEN | RXRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.4 | -3.2 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 16.3% | -0.6% |
| Gross Margin | -0.4% | -6.5% |
| Operating Margin | -0.3% | -19.9% |
| EPS | -1.33 | -1.12 |
| Dividend Yield | — | — |